All News
STAT+: Tara Schwetz, who oversaw creation of ARPA-H, placed on leave by NIH
The NIH has placed deputy director Tara Schwetz on administrative leave, marking the third senior leader to depart the agency since the Trump administration took power roughly nine weeks ago.
Read MoreAmericans Unhappier Than Ever; Smartphone Brain Rot? TikToks Miss Mark on ADHD
(MedPage Today) -- The U.S. ranked 24th on this year's World Happiness Report, falling to its lowest-ever spot.
Read MoreParents Downplay Measles Death; FDA Approval Questioned; Inside NIH Turmoil
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Read MorePulse Oximeter Basics
A pulse oximeter, or pulse ox, is a device that estimates the amount of oxygen in the blood. Here’s what to know before using one.
Read MoreTrump administration says it will pull back billions in Covid funding from local health departments
Federal health officials said Tuesday they are pulling back $11.4 billion in COVID-19-related funds for state and local public health departments and other health organizations throughout the nation.
Read MoreOlder Adults Favor Medicare Coverage for Obesity Meds
(MedPage Today) -- In a national poll of older adults, interest in using weight management medications was high, and most thought Medicare should cover these drugs.
Read MoreDaily physical activity, even at light intensities, linked to lower cancer risk
NIH study finds number of steps taken daily may be more important for cancer risk than the intensity of activity.
Read MoreU.S. to End Vaccine Funds for Poor Countries
A 281-page spreadsheet obtained by The Times lists the Trump administration’s plans for thousands of foreign aid programs.
Read MoreResearchers in Limbo as Columbia Bows to Trump's Demands in Bid to Restore Funding
(MedPage Today) -- When President Donald Trump canceled $400 million in funding to Columbia University over its handling of student protests against Israel's war in Gaza, much of the financial pain f
Read MoreSTAT+: Recent pharma-telehealth partnerships feel ‘black boxy,’ and why that’s problematic
A new kind of pharma-telehealth partnership has come under scrutiny over concerns that such an arrangement could lead to inappropriate prescriptions and poor care.
Read More